Public-registry site landscape for NCT07729462, a Preventive Treatment of Migraine study sponsored by Pfizer. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07729462 (registry record) |
| Sponsor | Pfizer |
| Condition(s) | Preventive Treatment of Migraine |
| Phase | PHASE3 |
| Listed sites | 2 |
| Site countries | United States |
At Hope Clinical Research — one of the facilities listed on this trial — 4 other studies are actively recruiting Preventive Treatment of Migraine patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07729462 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →